Extracorporeal albumin dialysis in a patient with primary sclerosing cholangitis: Effect on pruritus and bile acid profile

International Journal of Artificial Organs

Volumn 27, Issue 4, 2004, Pages 342-344

  Stauber, Rudolf E ^a   Krisper, P ^a   Zollner, G ^a   Iberer, F ^a   Beuers, U ^b   Trauner, M ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID;

ADSORBENT; ALBUMIN; BILE ACID; COLESTYRAMINE; NALOXONE; URSODEOXYCHOLIC ACID;

ADULT; ARTIFICIAL KIDNEY; BILE ACID BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; DISEASE SEVERITY; HEMODIALYSIS; HUMAN; LETTER; LIVER TRANSPLANTATION; MALE; MONITOR; PRIMARY SCLEROSING CHOLANGITIS; PRURITUS; VISUAL ANALOG SCALE;

EID: 2942656933     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880402700411     Document Type: Letter

References (13)

1. Bergasa NV, Jones EA. The pruritus of cholestasis. Semin Liver Dis 1993; 13: 319-27.
2. Datta DV, Sherlock S. Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis. Gastroenterology 1966; 50: 323-32.
3. Ghent CN, Carruthers SG. Treatment of pruritus in primary biliary cirrhosis with rifampin: results of a double-blind, crossover, randomized trial. Gastroenterology 1988; 94: 488-93.
4. Bergasa NV, Alling DW, Talbot TL, et al. Effects of naloxone infusions in patients with the pruritus of cholestasis: a double-blind, randomized, controlled trial. Ann Intern Med 1995; 123: 161-7.
5. Wolfhagen FH, Sternieri E, Hop WC, Vitale G, Bertolotti M, Van Buuren HR. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterology 1997; 113: 1264-9.
6. Lauterburg BH, Taswell HF, Pineda AA, Dickson ER, Burgstaler EA, Carlson GL. Treatment of pruritus of cholestasis by plasma perfusion through USP-charcoal-coated glass beads. Lancet 1980; ii: 53-5.
7. Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R. Albumin dialysis using the molecular adsorbent recirculating system. Curr Opin Nephrol Hypertens 2001; 10: 777-3.
8. Müllhaupt B, Kullak-Ublick GA, Ambühl PM, Stocker R, Renner EL. Successful use of the molecular adsorbent recirculating system (MARS) in a patient with primary biliary cirrhosis (PBC) and treatment refractory pruritus. Hepatol Res 2003; 25: 442-6.
9. Bellmann R, Graziadei IW, Feistritzer C, Schwaighofer H, Stellaard F, Sturm E, Wiedermann CJ, Joannidis M. Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis. Liver Transpl 2004; 10: 107-14.
10. Macia M, Aviles J, Navarro J, Morales S, Garcia J. Efficacy of molecular adsorbent recirculating system for the treatment of intractable pruritus in cholestasis. Am J Med 2003; 114: 62-4.
11. Doria C, Mandala L, Smith J, et al. Effect of molecular adsorbent recirculating system in hepatitis C virus-related intractable pruritus. Liver Transpl 2003; 9: 437-43.
12. Sturm E, Franssen CF, Gouw A, et al. Extracorporeal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC). Liver 2002; 22 (suppl 2): S72-5.
13. Beuers U, Spengler U, Zwiebel FM, Pauletzki J, Fischer S, Paumgartner G. Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease. Hepatology 1992; 15: 603-8.